Gerjan Navis

3.9k total citations
60 papers, 1.4k citations indexed

About

Gerjan Navis is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Surgery. According to data from OpenAlex, Gerjan Navis has authored 60 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 19 papers in Nephrology and 12 papers in Surgery. Recurrent topics in Gerjan Navis's work include Renal Transplantation Outcomes and Treatments (10 papers), Renin-Angiotensin System Studies (9 papers) and Dialysis and Renal Disease Management (8 papers). Gerjan Navis is often cited by papers focused on Renal Transplantation Outcomes and Treatments (10 papers), Renin-Angiotensin System Studies (9 papers) and Dialysis and Renal Disease Management (8 papers). Gerjan Navis collaborates with scholars based in Netherlands, United States and Italy. Gerjan Navis's co-authors include Stephan J. L. Bakker, Harry van Goor, Paul E. de Jong, Rijk O. B. Gans, Dick de Zeeuw, Eva Corpeleijn, Hans L. Hillege, Ronald P. Stolk, Ali Abbasi and Ron T. Gansevoort and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Kidney International.

In The Last Decade

Gerjan Navis

59 papers receiving 1.4k citations

Peers

Gerjan Navis
Przemysław Rutkowski Poland
Erdinç Çakır Türkiye
Tsutomu Sanaka Japan
Michal Herman Israel
H. Weihprecht United States
Mikio Okamura Japan
Brenner Bm United States
Else van den Berg Netherlands
Valeria Cernaro Italy
Hajime Nakahama Japan
Przemysław Rutkowski Poland
Gerjan Navis
Citations per year, relative to Gerjan Navis Gerjan Navis (= 1×) peers Przemysław Rutkowski

Countries citing papers authored by Gerjan Navis

Since Specialization
Citations

This map shows the geographic impact of Gerjan Navis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerjan Navis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerjan Navis more than expected).

Fields of papers citing papers by Gerjan Navis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerjan Navis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerjan Navis. The network helps show where Gerjan Navis may publish in the future.

Co-authorship network of co-authors of Gerjan Navis

This figure shows the co-authorship network connecting the top 25 collaborators of Gerjan Navis. A scholar is included among the top collaborators of Gerjan Navis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerjan Navis. Gerjan Navis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Post, Adrian, Firas Farisi Alkaff, Eva Corpeleijn, et al.. (2024). Association between objectively measured protein intake and muscle status, health-related quality of life, and mortality in hemodialysis patients. Clinical Nutrition ESPEN. 63. 787–795. 1 indexed citations
2.
Binnenmars, S. Heleen, Eva Corpeleijn, Arjan J. Kwakernaak, et al.. (2019). Impact of Moderate Sodium Restriction and Hydrochlorothiazide on Iodine Excretion in Diabetic Kidney Disease: Data from a Randomized Cross-Over Trial. Nutrients. 11(9). 2204–2204. 5 indexed citations
3.
Heilberg, Ita Pfeferman, et al.. (2015). Phosphate and FGF-23 homeostasis after kidney transplantation. Nature Reviews Nephrology. 11(11). 656–666. 43 indexed citations
4.
Schroten, Nicolas F., Kevin Damman, Mattia A. E. Valente, et al.. (2015). Long-term changes in renal function and perfusion in heart failure patients with reduced ejection fraction. Clinical Research in Cardiology. 105(1). 10–16. 19 indexed citations
5.
Waanders, Femke, et al.. (2014). Volume control in treatment-resistant congestive heart failure: role for peritoneal dialysis. Heart Failure Reviews. 19(6). 709–716. 5 indexed citations
6.
Abbasi, Ali, Eva Corpeleijn, Ron T. Gansevoort, et al.. (2014). Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study. Diabetologia. 57(9). 1842–1849. 24 indexed citations
7.
Borst, Martin H. de, Jelmer K. Humalda, Marc Vervloet, et al.. (2013). INCREASED PLASMA FIBROBLAST GROWTH FACTOR 23 IS ASSOCIATED WITH AN IMPAIRED RESPONSE TO ANTIPROTEINURIC THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE. Nephrology Dialysis Transplantation. 28. 23–24. 4 indexed citations
8.
Hofker, H. Sijbrand, Gerjan Navis, Jaap J. Homan van der Heide, et al.. (2013). Nonesterified Fatty Acids and Development of Graft Failure in Renal Transplant Recipients. Transplantation. 95(11). 1383–1389. 2 indexed citations
9.
Tudpor, Kukiat, Sergio Laínez, Arjan J. Kwakernaak, et al.. (2012). Urinary Plasmin Inhibits TRPV5 in Nephrotic-Range Proteinuria. Journal of the American Society of Nephrology. 23(11). 1824–1834. 21 indexed citations
10.
Berg, Else van den, et al.. (2011). HYPERTENSIVE KIDNEY DONORS PERFORM WELL AT SHORT TERM POST-DONATION FOLLOW-UP. Transplant International. 24. 160–161. 1 indexed citations
11.
Nijenhuis, Tom, Alexis Sloan, Joost G.J. Hoenderop, et al.. (2011). Angiotensin II Contributes to Podocyte Injury by Increasing TRPC6 Expression via an NFAT-Mediated Positive Feedback Signaling Pathway. American Journal Of Pathology. 179(4). 1719–1732. 174 indexed citations
12.
Zelle, Dorien M., et al.. (2011). Endogenous Plasma Erythropoietin, Cardiovascular Mortality and All-Cause Mortality in Renal Transplant Recipients. American Journal of Transplantation. 12(2). 485–491. 15 indexed citations
13.
Laverman, Gozewijn D. & Gerjan Navis. (2011). Improvement of Sodium Status to Optimize the Efficacy of Renin-Angiotensin System Blockade. Current Hypertension Reports. 13(6). 397–399. 1 indexed citations
14.
Navis, Gerjan, Stephan J. L. Bakker, & Pim van der Harst. (2010). Dissecting the genetics of complex traits: lessons from hypertension. Nephrology Dialysis Transplantation. 25(5). 1382–1385. 5 indexed citations
15.
Oterdoom, Leendert H., Aiko P. J. de Vries, Rutger M. van Ree, et al.. (2009). N-Terminal Pro-B-Type Natriuretic Peptide and Mortality in Renal Transplant Recipients Versus the General Population. Transplantation. 87(10). 1562–1570. 60 indexed citations
16.
Borst, Martin H. de, Sander H. Diks, Juliane Bolbrinker, et al.. (2007). Profiling of the renal kinome: a novel tool to identify protein kinases involved in angiotensin II-dependent hypertensive renal damage. American Journal of Physiology-Renal Physiology. 293(1). F428–F437. 17 indexed citations
17.
Laverman, Gozewijn D., Harry van Goor, Robert H. Henning, et al.. (2003). Renoprotective effects of VPI versus ACEI in normotensive nephrotic rats on different sodium intakes. Kidney International. 63(1). 64–71. 14 indexed citations
18.
Henning, Robert H., et al.. (2002). Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis. Kidney International. 61(2). 473–480. 19 indexed citations
19.
Buter, Hanneke, Gerjan Navis, Robin P. F. Dullaart, Dick de Zeeuw, & Paul E. de Jong. (2001). Time course of the antiproteinuric and renal haemodynamic responses to losartan in microalbuminuric IDDM. Nephrology Dialysis Transplantation. 16(4). 771–775. 35 indexed citations
20.
Navis, Gerjan, Coen A. Stegeman, Jaap A. Joles, et al.. (2001). Chronic blockade of angiotensin II action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation. The Journal of Pathology. 194(1). 122–129. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Przemysław Rutkowski Breakdown of academic impact, for papers by Erdinç Çakır Breakdown of academic impact, for papers by Tsutomu Sanaka Breakdown of academic impact, for papers by Michal Herman Breakdown of academic impact, for papers by H. Weihprecht Breakdown of academic impact, for papers by Mikio Okamura Breakdown of academic impact, for papers by Brenner Bm Breakdown of academic impact, for papers by Else van den Berg Breakdown of academic impact, for papers by Valeria Cernaro Breakdown of academic impact, for papers by Hajime Nakahama
Rankless by CCL
2026